Literature DB >> 14522142

Alpha-synuclein oligomerization: a role for lipids?

Kevin Welch1, Junying Yuan.   

Abstract

Alpha-Synuclein is a core component of the proteinaceous aggregates observed in several neurodegenerative diseases. A central role of alpha-synuclein in neurodegeneration was demonstrated by the discovery of missense alpha-synuclein mutations in familial Parkinson's disease. However, the specific mechanism by which alpha-synuclein contributes to these diseases remains unclear. A recent study by Sharon et al. linked the presence of specific fatty acids to the appearance of alpha-synuclein oligomers in vivo. alpha-Synuclein oligomers might be a first step in the formation of alpha-synuclein aggregates present in a number of neurodegenerative diseases, although their cytotoxicity remains to be directly demonstrated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522142     DOI: 10.1016/j.tins.2003.08.001

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  15 in total

1.  Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling.

Authors:  Christine C Jao; Ani Der-Sarkissian; Jeannie Chen; Ralf Langen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-20       Impact factor: 11.205

2.  Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Christopher M Dobson; Ad Bax
Journal:  J Mol Biol       Date:  2009-05-27       Impact factor: 5.469

3.  Peripheral sensory neurons survive in the absence of alpha- and gamma-synucleins.

Authors:  Katerina Papachroni; Natalia Ninkina; Julia Wanless; Anastasios Th Kalofoutis; Nikolai V Gnuchev; Vladimir L Buchman
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Organophosphate pesticides and PON1 L55M in Parkinson's disease progression.

Authors:  Kimberly C Paul; Janet S Sinsheimer; Myles Cockburn; Jeff M Bronstein; Yvette Bordelon; Beate Ritz
Journal:  Environ Int       Date:  2017-07-06       Impact factor: 9.621

5.  Structural intermediates during α-synuclein fibrillogenesis on phospholipid vesicles.

Authors:  Gemma Comellas; Luisel R Lemkau; Donghua H Zhou; Julia M George; Chad M Rienstra
Journal:  J Am Chem Soc       Date:  2012-03-12       Impact factor: 15.419

6.  Amyloidogenesis abolished by proline substitutions but enhanced by lipid binding.

Authors:  Ping Jiang; Weixin Xu; Yuguang Mu
Journal:  PLoS Comput Biol       Date:  2009-04-10       Impact factor: 4.475

7.  Syndromic approach to Parkinson's disease: role of functional imaging.

Authors:  Chong Sik Lee; Sun Ju Chung; Jae Seung Kim
Journal:  J Clin Neurol       Date:  2006-06-20       Impact factor: 3.077

8.  Role of Lipids in Brain Injury and Diseases.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Future Lipidol       Date:  2007-08

Review 9.  Altered lipid metabolism in brain injury and disorders.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Subcell Biochem       Date:  2008

10.  Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Alexander S Maltsev; Christopher M Dobson; Ad Bax
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.